Lessons learned from global serialization
Posted on June 14, 2017 by Helena Rogers
Pharmaceutical companies in the U.S, and the EU are currently preparing for new serialization requirements to enter into force, however it is clear that a number of companies are under-prepared and are unlikely to achieve compliance in sufficient time.
Several countries already have serialization regulations in place, providing companies who are yet to implement a serialization solution with examples of best practice to guide their own process.
There is still time to act ahead of the introduction of the European Falsified Medicines Directive (FMD) in 2019. In a piece for Contract Pharma, Carlos Machado, serialization director at SEA Vision U.S., outlines some of the key learnings from companies who have faced challenges in implementing serialization in the U.S, and highlights Turkey as a best practice example of serialization in operation.
You can read more about some of the lessons learned from global serialization here.